Laboratorios Farmaceuticos Rovi, S.A.
LABFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $178 | $220 | $258 | $183 |
| Dep. & Amort. | $28 | $24 | $23 | $21 |
| Deferred Tax | $0 | $0 | $0 | $14 |
| Stock-Based Comp. | $0 | $0 | $0 | $1 |
| Change in WC | $9 | -$34 | -$57 | -$64 |
| Other Non-Cash | -$76 | -$97 | $14 | -$6 |
| Operating Cash Flow | $138 | $113 | $238 | $149 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$62 | -$54 | -$51 | -$41 |
| Net Acquisitions | -$19 | $1 | $1 | $0 |
| Inv. Purchases | $0 | $0 | -$6 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$1 | $0 |
| Investing Cash Flow | -$81 | -$52 | -$57 | -$41 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $45 | -$13 | -$5 | -$5 |
| Stock Issued | $42 | $53 | $78 | $42 |
| Stock Repurch. | -$90 | -$134 | -$177 | -$79 |
| Dividends Paid | -$56 | -$69 | -$51 | -$21 |
| Other Fin. Act. | $4 | $2 | $1 | -$0 |
| Financing Cash Flow | -$55 | -$161 | -$155 | -$63 |
| Forex Effect | $0 | $0 | -$0 | $0 |
| Net Chg. in Cash | $2 | -$100 | $26 | $46 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $25 | $125 | $99 | $53 |
| End Cash | $27 | $25 | $125 | $99 |
| Free Cash Flow | $76 | $58 | $186 | $109 |